Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
about
Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on EarthThe anaemia of Plasmodium vivax malariaStructural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsImpact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidenceIsolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.Invertebrate immune systems--not homogeneous, not simple, not well understood.Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies.Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, IndonesiaMolecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malariaChloroquine resistance in Plasmodium vivax.Exploring the folate pathway in Plasmodium falciparum.Drug resistance hampers our capacity to roll back malaria.Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.A framework for assessing the risk of resistance for anti-malarials in development.Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia.How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii.Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia.
P2860
Q27003964-886CFED6-C47D-41A6-8EBF-F64C814B105DQ27026970-A326F91A-F7A3-4BCF-B5BF-7244A3BF6BD4Q27861940-A6EAC062-A8C1-4208-B8E4-C0CF9775525BQ28222513-BDCEBB63-178C-4B57-B18F-3FDE65CF4CD3Q30834598-251E3415-FAEE-406E-949D-FED10C38CD7DQ33664494-8D5B5EE1-6AB2-46F9-9A0D-F8C0CF8D813EQ33778751-9AB8547E-1CE7-4CAB-B9C2-C5B5F8534B9AQ35014243-AE543D06-D8B9-4B8E-BBE4-3FD0398D30A7Q35095652-4BE5153E-B75C-48C2-84BF-D8C8185BCA27Q35112348-08F8C85E-26B3-4055-A7FC-07272599BE96Q35927662-CF0BBC71-C4FF-4577-9CED-4938B4365C89Q36104143-8C9ACCB3-1A30-4305-89D7-C887A00B4BBBQ36201223-AAC2EA6C-D286-43C2-A6CA-64FC3385CDADQ36295369-F2AB0BDB-DF3D-42DE-8AA4-9807205AC52FQ36340996-B0B14D31-0421-467B-86C6-D3F3F19BF329Q36505818-A59973A3-147E-469A-91CC-C830C8C355FFQ36610773-4BF5A437-69B4-453E-BC1D-F0E916F942E6Q37390583-DD62F052-8C1F-4CBD-B5C7-776F8536AA82Q37425838-05211322-8060-4B08-A97F-F190FD6C7229Q37853675-000301BB-79A5-44D5-B0AB-9400AA48959DQ39468706-7D9CA7C7-1D2D-4BF6-AFE1-D07CD7EE245DQ40253940-33119DAB-2B54-426D-BE55-4608DD2E6963Q42112205-49E1FDC7-CB78-4A78-9492-68C6647BFD87Q42215707-88172178-624D-4C9E-9E03-7D3E17176FFAQ44731853-DEC8B460-E5EB-4DA1-B542-BC312C84C9E2
P2860
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@ast
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@en
type
label
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@ast
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@en
prefLabel
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@ast
Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
@en
P921
P356
P1476
Drug resistant falciparum malaria: clinical consequences and strategies for prevention
@en
P2093
P304
P356
10.1054/DRUP.2001.0195
P577
2001-06-01T00:00:00Z